CUAMC
KROS icon

China Universal Asset Management Company’s Keros Therapeutics KROS Stock Holding History

China Universal Asset Management Company’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.7K Sell
3,150
-2,256
-42% -$25.1K ﹤0.01% 479
2026
Q1 		$59.7K Buy
5,406
+442
+9% +$6.83K ﹤0.01% 448
2025
Q4 		$101K Sell
4,964
-2,155
-30% -$37.8K 0.01% 410
2025
Q3 		$113K Sell
7,119
-1,038
-13% -$15.3K 0.01% 378
2025
Q2 		$109K Buy
8,157
+21
+0.3% +$284 0.01% 361
2025
Q1 		$82.9K Sell
8,136
-453
-5% -$5.26K 0.01% 372
2024
Q4 		$136K Buy
8,589
+1,372
+19% +$71.3K 0.01% 363
2024
Q3 		$419K Buy
7,217
+2,978
+70% +$147K 0.05% 238
2024
Q2 		$194K Sell
4,239
-2,677
-39% -$144K 0.03% 248
2024
Q1 		$458K Buy
6,916
+3,456
+100% +$205K 0.06% 190
2023
Q4 		$138K Buy
3,460
+2,702
+356% +$84.7K 0.03% 247
2023
Q3 		$24.2K Buy
758
+370
+95% +$13.8K 0.01% 288
2023
Q2 		$15.6K Buy
388
+15
+4% +$658 ﹤0.01% 288
2023
Q1 		$15.9K Buy
373
+93
+33% +$4.7K 0.01% 244
2022
Q4 		$13.4K Buy
280
+39
+16% +$1.82K 0.01% 207
2022
Q3 		$9K Buy
+241
New +$8.35K ﹤0.01% 216

Other funds holding KROS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

China Universal Asset Management Company's KROS Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Keros Therapeutics (KROS) stake by 42% in Q2 2026, selling an estimated $25.1K and leaving 3,150 shares worth $33.7K. The position accounts for ﹤0.01% of the portfolio, ranked #479.

China Universal Asset Management Company first reported a position in KROS in Q3 2022 and has held it in 16 quarters since. The position peaked at $458K in Q1 2024. 56 funds tracked by Wall St. Rank hold KROS as of Q2 2026.

  • China Universal Asset Management Company held 3,150 shares of Keros Therapeutics worth $33.7K as of Q2 2026.
  • China Universal Asset Management Company sold 2,256 Keros Therapeutics shares in Q2 2026, an estimated $25.1K.
  • Keros Therapeutics made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #479 holding.
  • China Universal Asset Management Company first reported a position in Keros Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Keros Therapeutics position peaked at $458K in Q1 2024.
  • 56 funds tracked by Wall St. Rank held Keros Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.